Senior insider sale
GENERAL COUNSEL & CORP SEC at STOKE THERAPEUTICS, INC. — senior position signals high conviction
$818.0K
28.36K shares
What this filing means
ALLAN JONATHAN plans to sell 28.36K shares of STOKE THERAPEUTICS, INC. valued at approximately $818.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/8/2025ACC: 0001950047-25-009951
Officer· GENERAL COUNSEL & CORP SEC
Since Feb 2026
28.36K
Shares to sell
$818.0K
Approx. market value
3.98K
Acquired (3 months)
1
Planned
6 completed
Securities Acquired — Last 3 Months1
Performance Stock Units
N/A
12/3/2025
3.98KTotal acquired3.98K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/3/2025 | Performance Stock Units N/A | 3.98K | — |
| Total | 3.98K | ||
Planned & Completed Dispositions7
Completed
—Completed
Units to sell
7.78K
Market value
$243.4K
12/5/2025
—Completed
Units to sell
1K
Market value
$31.5K
12/5/2025
—Completed
Units to sell
1.02K
Market value
$31.4K
12/4/2025
—Completed
Units to sell
2.29K
Market value
$70.2K
12/3/2025
—Completed
Units to sell
2.28K
Market value
$68.0K
12/2/2025
—Completed
Units to sell
10K
Market value
$250.7K
10/3/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.98K
Market value
$122.8K
12/8/2025
Total
Units
28.36K
Value
$818.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/5/2025 | 7.78K | $243.4K | — | Completed |
12/5/2025 | 1K | $31.5K | — | Completed |
12/4/2025 | 1.02K | $31.4K | — | Completed |
12/3/2025 | 2.29K | $70.2K | — | Completed |
12/2/2025 | 2.28K | $68.0K | — | Completed |
10/3/2025 | 10K | $250.7K | — | Completed |
| Planned — Approximate Date | ||||
12/8/2025 | 3.98K | $122.8K | NASDAQ | Planned |
| Total | 28.36K | $818.0K | ||